These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean? Cohen AT; Khushal A Haemostasis; 2000; 30 Suppl 2():88-94; discussion 82-3. PubMed ID: 11251349 [TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168 [TBL] [Abstract][Full Text] [Related]
4. The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. Leclerc JR; Gent M; Hirsh J; Geerts WH; Ginsberg JS Chest; 1998 Aug; 114(2 Suppl Evidence):115S-118S. PubMed ID: 9726704 [No Abstract] [Full Text] [Related]
5. [Thromboprophylaxis with enoxaparin for total knee replacement: an observational, retrospective and multicentre study comparing starting the treatment before and after the operation]. Llau JV; Gil-Garay E; Castellet E; Rev Esp Anestesiol Reanim; 2012; 59(6):306-14. PubMed ID: 22738999 [TBL] [Abstract][Full Text] [Related]
6. [Risk and prevention of venous thromboembolic complications in surgery]. Baeshko AA Khirurgiia (Mosk); 2001; (4):61-9. PubMed ID: 11490498 [No Abstract] [Full Text] [Related]
7. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. Bergqvist D; Agnelli G; Cohen AT; Eldor A; Nilsson PE; Le Moigne-Amrani A; Dietrich-Neto F; N Engl J Med; 2002 Mar; 346(13):975-80. PubMed ID: 11919306 [TBL] [Abstract][Full Text] [Related]
8. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Eriksson BI; Agnelli G; Cohen AT; Dahl OE; Mouret P; Rosencher N; Eskilson C; Nylander I; Frison L; Ogren M; Thromb Haemost; 2003 Feb; 89(2):288-96. PubMed ID: 12574809 [TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement. Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915 [TBL] [Abstract][Full Text] [Related]
11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
12. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538 [TBL] [Abstract][Full Text] [Related]
13. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]
14. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy. Laufman H Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618 [No Abstract] [Full Text] [Related]
15. Safety and efficacy of postoperative pharmacologic thromboprophylaxis with enoxaparin after pancreatic surgery. Imamura H; Adachi T; Kitasato A; Tanaka T; Soyama A; Hidaka M; Fujita F; Takatsuki M; Kuroki T; Eguchi S Surg Today; 2017 Aug; 47(8):994-1000. PubMed ID: 28229301 [TBL] [Abstract][Full Text] [Related]
16. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lassen MR; Bauer KA; Eriksson BI; Turpie AG; Lancet; 2002 May; 359(9319):1715-20. PubMed ID: 12049858 [TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis after hip fracture: evaluation of 3 pharmacologic agents. Jeong GK; Gruson KI; Egol KA; Aharonoff GB; Karp AH; Zuckerman JD; Koval KJ Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3):135-40. PubMed ID: 17461395 [TBL] [Abstract][Full Text] [Related]
18. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group. Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557 [TBL] [Abstract][Full Text] [Related]
19. Antithromboembolic efficacy and safety of enoxaparin in general surgery. German multicentre trial. Haas S; Flosbach CW Eur J Surg Suppl; 1994; (571):37-43. PubMed ID: 7519088 [No Abstract] [Full Text] [Related]
20. [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark]. Olsen J; Gundgaard J; Borris LC Ugeskr Laeger; 2005 May; 167(21):2273-9. PubMed ID: 15962854 [No Abstract] [Full Text] [Related] [Next] [New Search]